---
title: "Ganesh Krishna, M.D., FCCP | Sutter Health"
description: "Ganesh Krishna, M.D., is Interventional Pulmonologist at PAMF's Mountain View campus. He has many interests in critical care medicine and pulmonary disease."
url: "https://www.sutterhealth.org/research/investigators/ganesh-krishna-md-fccp-1049681082"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Investigators](https://www.sutterhealth.org/research/investigators) /
4.  Ganesh Krishna, M.D., FCCP

![Ganesh Krishna, M.D., FCCP](https://dyn.mktgcdn.com/p/7HZoN6h0d4phO4VQYcU6TE-_Cn72_cBpIS3NRGru51E/fit=crop,gravity=auto,dpr=2,width=240,height=240)

# Ganesh Krishna, M.D., FCCP

Investigator

[View profile](https://www.sutterhealth.org/find-provider/dr-ganesh-krishna-1046236012)

Ganesh Krishna, MD, FCCP is a Professor of Medicine at the University of California, San Francisco (UCSF) and Director of the Interventional Pulmonary Program at PAMF/ECH. He specializes in pulmonary and critical care medicine, with advanced expertise in interventional pulmonology. Dr. Krishna completed his medical training in India before pursuing residency and fellowship training in the United States, including a pulmonary and critical care fellowship at Stanford University.

Board certified in internal medicine, pulmonary medicine, critical care medicine, and interventional pulmonology, Dr. Krishna has held academic and clinical leadership roles at Stanford and UCSF.

His work focuses on advanced bronchoscopic procedures, lung cancer diagnostics, and minimally invasive therapies for pulmonary disease. He has served as principal investigator on multiple clinical trials and has contributed extensively to peer-reviewed research in interventional pulmonology and lung disease.

His professional interests in critical care medicine include asthma, chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease, lung disease, pulmonary fibrosis, and pulmonary hypertension.

His interests in pulmonary disease include asbestos disease, cystic fibrosis, interstitial fibrosis, pulmonary fibrosis, and sarcoidosis

## Publications

-   Publication
    
    ### [Using a dedicated interventional pulmonology practice decreases wait time before treatment initiation for new lung cancer diagnoses.](https://www.sutterhealth.org/research/publications/interventionl-pulmonary-grp-decreases-time-to-tx-for-lung-ca-1055312409)
    
    Benn BS, Parikh M, Tsau PH, Seeley E, Krishna G.
    
    Lung. doi: 10.1007/s00408-019-00207-6. \[Epub ahead of print\]
    
    2019 Feb 19
    
-   Publication
    
    ### [A multicenter RCT of Zephyr® Endobronchial Valve treatment in heterogeneous emphysema (LIBERATE).](https://www.sutterhealth.org/research/publications/rct-zephyr-endobronchial-valve-tx-emphysema-liberate-1055312389)
    
    Criner GJ, Sue R, Wright S, Dransfield M, Rivas-Perez H, Wiese T, Sciurba FC, Shah PL, Wahidi MM, de Oliveira HG, Morrissey B, Cardoso PFG, Hays S, Majid A, Pastis N Jr, Kopas L, Vollenweider M, McFadden PM, Machuzak M, Hsia DW, Sung A, Jarad N, Kornaszewska M, Hazelrigg S, Krishna G, Armstrong B, Shargill NS, Slebos DJ; LIBERATE Study Group.
    
    Am J Respir Crit Care Med. doi: 10.1164/rccm.201803-0590OC. \[Epub ahead of print\]
    
    2018 May 22
    
-   Publication
    
    ### [Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure.](https://www.sutterhealth.org/research/publications/transbronchial-cryobx-dx-diffuse-parenchymal-lung-diseases-1055312384)
    
    Hetzel J, Maldonado F, Ravaglia C, Wells AU, Colby TV, Tomassetti S, Ryu JH, Fruchter O, Piciucchi S, Dubini A, Cavazza A, Chilosi M, Sverzellati N, Valeyre D, Leduc D, Walsh SLF, Gasparini S, Hetzel M, Hagmeyer L, Haentschel M, Eberhardt R, Darwiche K, Yarmus LB, Torrego A, Krishna G, Shah PL, Annema JT, Herth FJF, Poletti V.
    
    Respiration. doi: 10.1159/000484055. \[Epub ahead of print\]
    
    2018 Jan 09
    
-   Publication
    
    ### [Nivolumab-induced granulomatous inflammation of the pleura.](https://www.sutterhealth.org/research/publications/nivolumab-induced-granulomat-inflammatn-pleura-1055312317)
    
    Benn BS, Lombard CM, Krishna G.
    
    J Thorac Oncol. 12(7):e100-e101. doi: 10.1016/j.jtho.2017.03.006.
    
    2017 Jul 01
    
-   Publication
    
    ### [Endobronchial ultrasound-guided transbronchial needle injection of liposomal amphotericin B for the treatment of symptomatic aspergilloma.](https://www.sutterhealth.org/research/publications/endobrachial-injection-amphotericin-b-aspergilloma-1055312303)
    
    Parikh MS, Seeley E, Nguyen-Tran E, Krishna G.
    
    J Bronchology Interv Pulmonol. doi: 10.1097/LBR.0000000000000383. \[Epub ahead of print\]
    
    2017 Jun 05
    

...

Page 1 of 6

## Research studies

-   Research study
    
    ### [Emphysema Severe Spiration® Valve System (SVS) Post-Market Registry STRIVE](https://www.sutterhealth.org/research/studies/emphysema-severe-spiration-valve-system-svs-post-market-registry-strive-2059712903)
    
    The Spiration® Valve System (SVS) Post-Market Registry Study for Severe Emphysema

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/ganesh-krishna-md-fccp-1049681082#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"Ganesh Krishna, M.D., FCCP"}]}
```

```json
{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/ganesh-krishna-md-fccp-1049681082#profilepage","url":"https://www.sutterhealth.org/research/investigators/ganesh-krishna-md-fccp-1049681082","name":"Ganesh Krishna, M.D., FCCP","dateModified":"2026-06-04","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/ganesh-krishna-md-fccp-1049681082#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/7HZoN6h0d4phO4VQYcU6TE-_Cn72_cBpIS3NRGru51E/191x191.jpg","width":191,"height":191},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/ganesh-krishna-md-fccp-1049681082"}}
```

```json
{"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/ganesh-krishna-md-fccp-1049681082","name":"Ganesh Krishna, M.D., FCCP","givenName":"Ganesh","familyName":"Krishna","honorificSuffix":"M.D., FCCP","description":"Ganesh Krishna, MD, FCCP is a Professor of Medicine at the University of California, San Francisco (UCSF) and Director of the Interventional Pulmonary Program at PAMF/ECH. He specializes in pulmonary and critical care medicine, with advanced expertise in interventional pulmonology. Dr. Krishna completed his medical training in India before pursuing residency and fellowship training in the United States, including a pulmonary and critical care fellowship at Stanford University. Board certified in internal medicine, pulmonary medicine, critical care medicine, and interventional pulmonology, Dr. Krishna has held academic and clinical leadership roles at Stanford and UCSF. His work focuses on advanced bronchoscopic procedures, lung cancer diagnostics, and minimally invasive therapies for pulmonary disease. He has served as principal investigator on multiple clinical trials and has contributed extensively to peer-reviewed research in interventional pulmonology and lung disease. His professional interests in critical care medicine include asthma, chronic obstructive pulmonary disease, cystic fibrosis, interstitial lung disease, lung disease, pulmonary fibrosis, and pulmonary hypertension. His interests in pulmonary disease include asbestos disease, cystic fibrosis, interstitial fibrosis, pulmonary fibrosis, and sarcoidosis","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/7HZoN6h0d4phO4VQYcU6TE-_Cn72_cBpIS3NRGru51E/191x191.jpg","representativeOfPage":true},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/ganesh-krishna-md-fccp-1049681082#profilepage"},"sameAs":"https://www.sutterhealth.org/find-provider/dr-ganesh-krishna-1046236012"}
```
